Fundraising Fox

Hugh Davis

Executive at Aclaris Therapeutics

Wayne, Pennsylvania, United States

Find your path to Hugh

225 people in our graph share verified history with Hugh — schools, employers, funds. One of them is your warm intro.

Teresa ChanunlockedHugh: together at Johnson & Johnson (2002–2004)
×11Hugh: together at Johnson & Johnson

Executive at Aclaris Therapeutics

Intro paths

→

In turn, Hugh can intro founders to Aclaris Therapeutics's investors below.

Aclaris Therapeutics's investors · 8

Aisling CapitalNew YorkAPERTURE Venture PartnersBoston · $1M – $5M checksF-Prime CapitalCambridge · $3M – $10M checksForesite CapitalWest HollywoodRA CapitalBostonSofinnova Venture PartnersMenlo Park · since 2020Sofinnova VenturesMenlo Park · $100K – $15M checksVivo CapitalPalo Alto · $10M – $50M checks

Co-founders at Aclaris Therapeutics

NW
Neal WalkerExecutive Officer, Director
KA
Kamil Ali-JacksonExecutive Officer
SDStuart D. Shanler
Stuart D. ShanlerExecutive Officer

Experience

  1. Aclaris Therapeutics, Inc.President, Chief Operating Officer and Member of the Board of Directorscurrent2024 — present
  2. Biosion, Inc.Chief Business and Dev. Officer & President, Biosion USA, Inc. and Member of the Board of Directors2020 — 2024Newark, Delaware, United States
  3. Frontage Laboratories, IncChief Business Officer2018 — 2020Exton, PA
  4. Janssen BioTherapeuticsVP & Head, Biologics Development Sciences and Janssen BioTherapeutics China Biologics Leader2016 — 2018Spring House, PA
  5. Janssen Research & Development, LLCVice President, Head, Biologics Clinical Pharmacology and China Biologics Leader, Biotechnology CoE2014 — 2018Spring House, PA
  6. Johnson & JohnsonVice President, Biologics Clinical Pharmacology2001 — 2018
  7. Centocor, Chesterbrook, PAVice President, Biologics Clinical Pharmacology2010 — 2011
  8. CentocorVice President and Head, Biologics Clinical Pharmacology2006 — 2010
  9. CentocorVP, Biologics Clinical Pharmacology2001 — 2009

Skills & more

Clinical Development26Clinical Pharmacology24Pharmaceutical Industry34Biologics69Drug Development34Oncology16Immunology17Validation3CRO8Medical Affairs3Biotechnology56Clinical Trials11
+8 moreTranslational MedicineGCPClinical ResearchInfectious DiseasesLife SciencesBiopharmaceuticalsDrug DiscoveryRegulatory Submissions

From Hugh's professional profile.

Frequently asked questions

Who is Hugh Davis?
Executive Officer, Director at Aclaris Therapeutics
Where does Hugh Davis work?
Hugh Davis is Executive at Aclaris Therapeutics.
Where did Hugh Davis go to school?
Hugh Davis studied at Villanova University (Ph.D., Biochemistry); Villanova University (Master of Science (M.S.), Biochemistry).

Same school

Also attended Villanova University177

Connor HillAssistant Controller at GreycroftEric JohnsonInvestor at Khosla VenturesJessica MayerClient Team Member at Generation Investment ManagementAndrea CambriaPrincipal, Head of Valuation at TCVDeb TraversEntrepreneur-In-Residence at The Innovation SpaceKaki CaceresVice President, Finance at Stripes

+ 171 more

Shared employers

Also worked at Aclaris Therapeutics, Inc.2

Kevin BalthaserExecutive Officer at Aclaris TherapeuticsMichael TungExecutive Vice President and Chief Financial Officer at Vtvtherapeutics

Also worked at Frontage Laboratories, Inc1

Elena SmithSr Director People at Klue

Also worked at Janssen Research & Development, LLC66

Patrick LoerchBio Advisor at Amplify PartnersUmut EserVenture Partner at Magnetic VenturesLance BermanVenture Partner at Ysios CapitalJuan CuevaDirector, Early Innovation Partnering at Johnson & Johnson at Joyance PartnersPatrick ForsterInvestment Analyst at The Spartan GroupMichael KalosInvestor at 82VS

+ 60 more

Also worked at Johnson & Johnson281

Teresa ChanChief Financial Officer at Felicis VenturesKarthik ArdhanareeswaranInvestor at GV (Google Ventures)KobeFinance Director at Hummingbird VenturesMickelFinance & Risk Management at Hummingbird VenturesHal PazInvestor at Khosla VenturesNiall O'DonnellManaging Director at RiverVest Venture Partners

+ 275 more